Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

被引:1413
作者
Mandala, S
Hajdu, R
Bergstrom, J
Quackenbush, E
Xie, J
Milligan, J
Thornton, R
Shei, GJ
Card, D
Keohane, C
Rosenbach, M
Hale, J
Lynch, CL
Rupprecht, K
Parsons, W
Rosen, H
机构
[1] Merck Res Labs, Dept Immunol & Rheumatol, Rahway, NJ 07055 USA
[2] Merck Res Labs, Dept Pharmacol, Rahway, NJ 07055 USA
[3] Merck Res Labs, Dept Med Chem, Rahway, NJ 07055 USA
关键词
D O I
10.1126/science.1070238
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Blood lymphocyte numbers, essential for the development of efficient immune responses, are maintained by recirculation through secondary Lymphoid organs. We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720. Both species were high-affinity agonists of at Least four of the five S1P receptors. These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen. S1P receptor agonists induced emptying of lymphoid sinuses by retention of Lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph. Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.
引用
收藏
页码:346 / 349
页数:4
相关论文
共 23 条
  • [1] Chemokines in lymphopoiesis and lymphoid organ development
    Ansel, KM
    Cyster, JG
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (02) : 172 - 179
  • [2] FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
    Brinkmann, V
    Pinschewer, D
    Chiba, K
    Feng, LL
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (02) : 49 - 52
  • [3] FTY720: Altered lymphocyte traffic results in allograft protection.
    Brinkmann, V
    Pinschewer, DD
    Feng, L
    Chen, S
    [J]. TRANSPLANTATION, 2001, 72 (05) : 764 - 769
  • [4] Lymphocyte trafficking and regional immunity
    Butcher, EC
    Williams, M
    Youngman, K
    Rott, L
    Briskin, M
    [J]. ADVANCES IN IMMUNOLOGY, VOL. 72, 1999, 72 : 209 - 253
  • [5] The identification of myriocin-binding proteins
    Chen, JK
    Lane, WS
    Schreiber, SL
    [J]. CHEMISTRY & BIOLOGY, 1999, 6 (04): : 221 - 235
  • [6] Chiba K, 1998, J IMMUNOL, V160, P5037
  • [7] Lysophospholipid receptors
    Fukushima, N
    Ishii, I
    Contos, JJA
    Weiner, JA
    Chun, J
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 : 507 - 534
  • [8] Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement
    Garcia, JGN
    Liu, F
    Verin, AD
    Birukova, A
    Dechert, MA
    Gerthoffer, WT
    Bamburg, JR
    English, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (05) : 689 - 701
  • [9] The lymphocyte - A disgraceful gap in medical knowledge
    Gowans, JL
    [J]. IMMUNOLOGY TODAY, 1996, 17 (06): : 288 - 291
  • [10] Gräler MH, 1999, CURR TOP MICROBIOL, V246, P131